Literature DB >> 24770349

Severe and morbid obesity (BMI ≥ 35 kg/m(2)) does not increase surgical time and length of hospital stay in total knee arthroplasty surgery.

Luis M Lozano1, Monserrat Tió, J Rios, Gerard Sanchez-Etayo, Dragos Popescu, Sergi Sastre, Misericordia Basora.   

Abstract

PURPOSE: Certain aspects of total knee arthroplasty (TKA) in severely and morbidly obese (SMO) patients (BMI ≥ 35 kg/m(2)) remain controversial. This study aimed to assess the duration of TKA surgery and hospital stay in relation to patients' BMI.
METHODS: Three operative times during TKA surgery were recorded: tourniquet time, to determine surgical difficulty, total surgical time, to assess the difficulty of achieving anaesthesia, and time in the surgical area, to assess patient management in the surgical area. Length of hospital stay was also calculated. Data were collected prospectively from consecutive patients and were recorded in a database for retrospective analysis.
RESULTS: Data were obtained from 922 consecutive patients undergoing TKA. The non-obese group comprised 418 patients (45.3%), obese group Class I 331 (36%), and the SMO group (Class II-III) 173 (18.7%). Mean tourniquet time was 53 min, mean total surgical time was 84 min, and mean time in the surgical area was 132 min. There were no differences according to BMI group. Median length hospital stay (LHS) was 6 days in all patients regardless of BMI. Factors that significantly prolonged LHS were ASA III-IV and pre-operative haemoglobin between 12 and 13 g/dl.
CONCLUSION: Severely and morbidly obese (SMO) patients (BMI ≥ 35 kg/m(2)) undergoing TKA surgery do not require longer operative time or hospital stay than non-obese or obese Class I patients. The fact that surgical time was not significantly different could be due to greater specialisation in the treatment of these patients, which may favour a lower incidence of post-operative complications. LEVEL OF EVIDENCE: Retrospective comparative study, Level IV.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770349     DOI: 10.1007/s00167-014-3002-9

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  37 in total

Review 1.  Regional anaesthesia in the obese patient: lost landmarks and evolving ultrasound guidance.

Authors:  Jay B Brodsky; Edward R Mariano
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2011-03

2.  Good quality of life in severely obese total knee replacement patients: a case-control study.

Authors:  Montserrat Núñez; Luis Lozano; Esther Núñez; Sergi Sastre; José Luis Del Val; Santiago Suso
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

3.  Higher body mass index leads to longer operative time in total knee arthroplasty.

Authors:  Barthelemy Liabaud; David A Patrick; Jeffrey A Geller
Journal:  J Arthroplasty       Date:  2012-11-08       Impact factor: 4.757

4.  Factors influencing health-related quality of life after TKA in patients who are obese.

Authors:  Montserrat Nuñez; Lluis Lozano; Esther Nuñez; Josep-Maria Segur; Sergi Sastre
Journal:  Clin Orthop Relat Res       Date:  2010-11-23       Impact factor: 4.176

5.  Obesity and knee osteoarthritis. The Framingham Study.

Authors:  D T Felson; J J Anderson; A Naimark; A M Walker; R F Meenan
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

6.  Relationship between knee anthropometry and surgical time in total knee arthroplasty in severely and morbidly obese patients: a new prognostic index of surgical difficulty.

Authors:  L M Lozano; M Núñez; J M Segur; F Maculé; S Sastre; E Núñez; S Suso
Journal:  Obes Surg       Date:  2008-05-28       Impact factor: 4.129

Review 7.  The epidemic of obesity.

Authors:  Cynthia J Stein; Graham A Colditz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Role of obesity on the risk for total hip or knee arthroplasty.

Authors:  Robert Bourne; Shaheena Mukhi; Naisu Zhu; Margaret Keresteci; Mihaela Marin
Journal:  Clin Orthop Relat Res       Date:  2007-12       Impact factor: 4.176

Review 9.  Osteoarthritis: new insights. Part 1: the disease and its risk factors.

Authors:  D T Felson; R C Lawrence; P A Dieppe; R Hirsch; C G Helmick; J M Jordan; R S Kington; N E Lane; M C Nevitt; Y Zhang; M Sowers; T McAlindon; T D Spector; A R Poole; S Z Yanovski; G Ateshian; L Sharma; J A Buckwalter; K D Brandt; J F Fries
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

Review 10.  The role of surgeon volume on patient outcome in total knee arthroplasty: a systematic review of the literature.

Authors:  Rick L Lau; Anthony V Perruccio; Rajiv Gandhi; Nizar N Mahomed
Journal:  BMC Musculoskelet Disord       Date:  2012-12-14       Impact factor: 2.362

View more
  5 in total

1.  The Effect of Age upon the Interrelationship of BMI and Inpatient Health Outcomes.

Authors:  C Woolley; C Thompson; P Hakendorf; C Horwood
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  Patellar non-eversion in primary TKA reduces the complication rate.

Authors:  Guangpu Yang; Wenfa Huang; Weixin Xie; Zhipeng Liu; Meimei Zheng; Yuxing Hu; Jing Tian
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-02-13       Impact factor: 4.342

3.  Predictive factors of length of hospital stay after primary total knee arthroplasty.

Authors:  Lotte van den Belt; Peter van Essen; Petra J C Heesterbeek; Koen C Defoort
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-09-20       Impact factor: 4.342

4.  Effect of body mass index on duration of total knee replacement surgery: A prospective cross sectional study.

Authors:  Zamin Abbas; Sohail Hafeez; Ali Naseem; Yasir Habib; Hassan Mumtaz
Journal:  Ann Med Surg (Lond)       Date:  2022-09-23

5.  Effect of body mass index on surgical times of lumbar laminoplasty and lower limb arthroplasties.

Authors:  Kengo Harato; Mitsuru Yagi; Nobuyuki Fujita; Shu Kobayashi; Akihito Ohya; Kazuya Kaneda; Yu Iwama; Masaya Nakamura; Morio Matsumoto
Journal:  BMC Musculoskelet Disord       Date:  2019-09-06       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.